Literature DB >> 31411522

Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review.

Yaofei Jiang1, Zijie Mei1, Hong Cao2, Sirui Li3, Haibo Xu3, Hui Qiu1, Yu Liu1.   

Abstract

Malignant peritoneal mesothelioma is a very rare tumor originating from the peritoneal serous mesothelium. Meningeal metastasis of malignant peritoneal is even more rare. Here, we reported a case of a 60-year-old female patient with a history of exposure to asbestos for 10 years who presented with massive peritoneal effusion followed by disorder of consciousness and symptoms of cranial nerve injury. The patient was diagnosed as peritoneal mesothelioma with meningeal metastasis through neurological symptoms, cytological finding of cerebrospinal fluid combined with cranial magnetic resonance imaging (MRI). The patient received systemic chemotherapy and total craniospinal irradiation. The follow up visits showed that the survival time of patient after diagnosis of meningeal metastasis from peritoneal mesothelioma was 5 months. To our knowledge, this is the first case of menigeal metastasis of peritoneal mesothelioma. We hope this particular case may be helpful in providing some experience to the treatment of peritoneal mesothelioma with meningeal metastasis.

Entities:  

Keywords:  Malignant peritoneal mesothelioma; asbestos exposure; craniospinal irradiation; meningeal metastasis

Mesh:

Substances:

Year:  2019        PMID: 31411522      PMCID: PMC6804805          DOI: 10.1080/15384047.2019.1647053

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  36 in total

1.  Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy.

Authors:  A M Amin; C Mason; P Rowe
Journal:  Eur J Surg Oncol       Date:  2001-03       Impact factor: 4.424

Review 2.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

Review 3.  Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies.

Authors:  J Remon; N Reguart; J Corral; P Lianes
Journal:  Cancer Treat Rev       Date:  2014-11-08       Impact factor: 12.111

Review 4.  Pathology of malignant mesothelioma.

Authors:  R L Attanoos; A R Gibbs
Journal:  Histopathology       Date:  1997-05       Impact factor: 5.087

5.  Unusual clear cell variant of epithelioid mesothelioma.

Authors:  E Dessy; M Falleni; P Braidotti; B Del Curto; T Panigalli; G G Pietra
Journal:  Arch Pathol Lab Med       Date:  2001-12       Impact factor: 5.534

6.  Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias.

Authors:  J G Kaplan; T G DeSouza; A Farkash; B Shafran; D Pack; F Rehman; J Fuks; R Portenoy
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

7.  Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.

Authors:  Jennifer J Jordan; Alberto Inga; Kathleen Conway; Sharon Edmiston; Lisa A Carey; Lin Wu; Michael A Resnick
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

8.  A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

Authors:  Vito Lorusso; Enrico Crucitta; Nicola Silvestris; Michele Guida; Andrea Misino; Agnese Latorre; Mario De Lena
Journal:  Clin Breast Cancer       Date:  2003-06       Impact factor: 3.225

9.  Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.

Authors:  Lucas G Chase; Sufang Yang; Vladimir Zachar; Zheng Yang; Uma Lakshmipathy; Jolene Bradford; Shayne E Boucher; Mohan C Vemuri
Journal:  Stem Cells Transl Med       Date:  2012-10-10       Impact factor: 6.940

10.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.